Effectiveness of smoking cessation interventions among persons with cancer: A systematic review.
neoplasms
psycho-oncology
smoking cessation
systematic review
tobacco use
tobacco use cessation
Journal
Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
08
05
2023
received:
13
02
2023
accepted:
11
05
2023
medline:
9
8
2023
pubmed:
25
5
2023
entrez:
25
5
2023
Statut:
ppublish
Résumé
Continued smoking after cancer diagnosis is associated with worse outcomes, however, many persons diagnosed with cancer who smoke are unable to quit successfully. Effective interventions are needed to promote quitting in this population. The purpose of this systematic review is to understand the most effective interventions for smoking cessation among persons with cancer and to identify gaps in knowledge and methodology to suggest directions for future research. Three electronic databases (The Cochrane Central Register of Controlled trials, MEDLINE, and EMBASE) were searched for studies of smoking cessation interventions among persons with cancer, published up to 1 July 2021. Title and abstract screening, full-text review, and data extraction was completed by two independent reviewers, via Covalence software, with any discordance resolved by a third reviewer. A quality assessment was completed using the Cochrane Risk of Bias Tool Version 2. Thirty-six articles were included in the review, including 17 randomized-controlled trials (RCTs) and 19 non-RCT studies. Of the 36 studies, 28 (77.8%) utilized an intervention that included both counseling and medication, with 24 (85.7%) providing medication to participants at no cost. Abstinence rates in the RCT intervention groups (n = 17) ranged from 5.2% to 75%, while the non-RCTs found abstinence rates ranging from 15% to 46%. Overall, studies met a mean of 2.28 out of seven quality items, ranging from 0 to 6. Our study highlights the importance of utilizing intensive combined behavioral and pharmacological interventions for persons with cancer. While combined therapy interventions seem to be the most effective, more research is needed, as current studies have several quality issues, including the lack of biochemical verification for abstinence.
Types de publication
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1147-1162Informations de copyright
© 2023 The Authors. Psycho-Oncology published by John Wiley & Sons Ltd.
Références
National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and H. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Centers for Disease Control and Prevention (US); 2014.
Jassem J. Tobacco smoking after diagnosis of cancer: clinical aspects. Transl Lung Cancer Res. 2019;8(Suppl 1):S50-S58. https://doi.org/10.21037/tlcr.2019.04.01
Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401-410. https://doi.org/10.1002/ijc.27617
Videtic GMM, Stitt LW, Dar AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol. 2003;21(8):1544-1549. https://doi.org/10.1200/jco.2003.10.089
Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340(jan21 1):b5569. https://doi.org/10.1136/bmj.b5569
Schnoll RA, Zhang B, Rue M, et al. Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the eastern cooperative oncology group. J Clin Oncol. 2003;21(2):355-365. https://doi.org/10.1200/jco.2003.04.122
Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569-576. https://doi.org/10.1002/1097-0142(19950115)75:2<569::aid-cncr2820750221>3.0.co;2-i
Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328(3):159-163. https://doi.org/10.1056/nejm199301213280302
Florou AN, Gkiozos IC, Tsagouli SK, Souliotis KN, Syrigos KN. Clinical significance of smoking cessation in subjects with cancer: a 30-year review. Respir Care. 2014;59(12):1924-1936. https://doi.org/10.4187/respcare.02559
Paul CL, Tzelepis F, Boyes AW, D'Este C, Sherwood E, Girgis A. Continued smoking after a cancer diagnosis: a longitudinal study of intentions and attempts to quit. J Cancer Surviv Res Pract. 2019;13(5):687-694. https://doi.org/10.1007/s11764-019-00787-5
Berg CJ, Thomas AN, Mertens AC, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho Oncol. 2013;22(4):799-806. https://doi.org/10.1002/pon.3077
Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer. 2006;106(1):17-27. https://doi.org/10.1002/cncr.21598
Guimond A.-J, Croteau VA, Savard M.-H, Bernard P, Ivers H, Savard J. Predictors of smoking cessation and relapse in cancer patients and effect on psychological variables: an 18-month observational study. Ann Behav Med Publ Soc Behav Med. 2017;51(1):117-127. https://doi.org/10.1007/s12160-016-9834-4
Simmons VN, Sutton SK, Meltzer LR, et al. Preventing smoking relapse in patients with cancer: a randomized controlled trial. Cancer. 2020;126(23):5165-5172. https://doi.org/10.1002/cncr.33162
Walker MS, Vidrine DJ, Gritz ER, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2370-2377. https://doi.org/10.1158/1055-9965.epi-06-0509
Karam-Hage M, Cinciripini PM, Gritz ER. Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin. 2014;64(4):272-290. https://doi.org/10.3322/caac.21231
Kumar R, Prasad R. Smoking cessation: an update. Indian J Chest Dis Allied Sci. 2022;56(3):161-169. https://doi.org/10.5005/ijcdas-56-3-161
Guerriero C, Cairns J, Roberts I, Rodgers A, Whittaker R, Free C. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop. Eur J Health Econ. 2013;14(5):789-797. https://doi.org/10.1007/s10198-012-0424-5
Yingst JM, Veldheer S, Hrabovsky S, et al. Pilot randomized trial of an automated smoking cessation intervention via mobile phone text messages as an adjunct to varenicline in primary care. J Health Commun. 2018;23(4):370-378. https://doi.org/10.1080/10810730.2018.1453890
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane database Syst Rev. 2019;10:CD006611. https://doi.org/10.1002/14651858.cd006611.pub5
Siu AL, Force USPST. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2015;163(8):622-634. https://doi.org/10.7326/m15-2023
Nayan S, Gupta MK, Sommer DD. Evaluating smoking cessation interventions and cessation rates in cancer patients: a systematic review and meta-analysis. ISRN Oncol. 2011;2011:849023-849027. https://doi.org/10.5402/2011/849023
Nayan S, Gupta MK, Strychowsky JE, Sommer DD. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol-Head Neck Surg. 2013;149(2):200-211. https://doi.org/10.1177/0194599813490886
Shea BJ, Reeves BC, Wells G, et al. Amstar 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https://doi.org/10.1136/bmj.j4008
Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928. https://doi.org/10.1136/bmj.d5928
Rettig EM, Fakhry C, Hales RK, et al. Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy. Head Neck. 2018;40(7):1534-1547. https://doi.org/10.1002/hed.25148
Clinical practice guideline treating tobacco use and dependence 2008 update panel La, and staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public health service report. Am J Prev Med. 2008;35(2):158-176.
Aksel O, Küçüktepe N, Yaslıca Z, Başak O. Providing free access to smoking cessation medications: does it have an impact on the treatment adherence and success of smoking cessation? Turk Thorac J. 2021;22(3):224-230. https://doi.org/10.5152/turkthoracj.2021.20124
Piper ME, Bullen C, Krishnan-Sarin S, et al. Defining and measuring abstinence in clinical trials of smoking cessation interventions: an updated review. Nicotine Tob Res. 2020;22(7):1098-1106. https://doi.org/10.1093/ntr/ntz110
Benowitz NL, Bernert JT, Foulds J, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res. 2020;22(7):1086-1097. https://doi.org/10.1093/ntr/ntz132
Krebs P, Burkhalter J, Fiske J, et al. The QuitIT coping skills game for promoting tobacco cessation among smokers diagnosed with cancer: pilot randomized controlled trial. JMIR mHealth uHealth. 2019;7(1):e10071. https://doi.org/10.2196/10071
Schnoll R, Leone F, Veluz-Wilkins A, et al. A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence. Psycho Oncol. 2019;28(3):561-569. https://doi.org/10.1002/pon.4978
Schnoll RA, Martinez E, Tatum KL, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control. 2010;21(6):811-820. https://doi.org/10.1007/s10552-010-9507-8
Crawford G, Weisbrot J, Bastian J, et al. Predictors of varenicline adherence among cancer patients treated for tobacco dependence and its association with smoking cessation. Nicotine Tob Res. 2019;21(8):1135-1139. https://doi.org/10.1093/ntr/nty133
Schnoll RA, Martinez E, Langer C, Miyamoto C, Leone F. Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program. Acta Oncol. 2011;50(5):678-684. https://doi.org/10.3109/0284186x.2011.572915
Carroll AJ, Veluz-Wilkins AK, Blazekovic S, et al. Cancer-related disease factors and smoking cessation treatment: analysis of an ongoing clinical trial. Psycho Oncol. 2018;27(2):471-476. https://doi.org/10.1002/pon.4483
Li WHC, Wang MP, Ho KY, et al. Helping cancer patients quit smoking using brief advice based on risk communication: a randomized controlled trial. Sci Rep. 2018;8(1):2712. https://doi.org/10.1038/s41598-018-21207-1
Rojewski AM, Fucito LM, Baker NL, et al. A preoperative contingency management intervention for smoking abstinence in cancer patients: a preliminary randomized controlled trial. Nicotine Tob Res. 2021;23(6):1064-1067. https://doi.org/10.1093/ntr/ntaa266
Wakefield M, Olver I, Whitford H, Rosenfeld E. Motivational interviewing as a smoking cessation intervention for patients with cancer: randomized controlled trial. Nurs Res. 2004;53(6):396-405. https://doi.org/10.1097/00006199-200411000-00008
Tuck BM, Karelitz JL, Tomko RL, Dahne J, Cato P, McClure EA. Mobile, remote, and individual focused: comparing breath carbon monoxide readings and abstinence between smartphone-enabled and stand-alone monitors. Nicotine Tob Res. 2021;23(4):741-747. https://doi.org/10.1093/ntr/ntaa203
Karelitz JL, Michael VC, Perkins KA. Analysis of agreement between expired-air carbon monoxide monitors. J Smok Cessat. 2017;12(2):105-112. https://doi.org/10.1017/jsc.2015.18
Ostroff JS, Burkhalter JE, Cinciripini PM, et al. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. Health Psychol. 2014;33(7):737-747. https://doi.org/10.1037/a0033186
Park ER, Perez GK, Regan S, et al. Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer. JAMA. 2020;324(14):1406. https://doi.org/10.1001/jama.2020.14581
Park ER, Japuntich S, Temel J, et al. A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial. J Thorac Oncol. 2011;6(6):1059-1065. https://doi.org/10.1097/jto.0b013e318215a4dc
Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res. 2011;2(3):109-112. https://doi.org/10.4103/2229-3485.83221
McCoy CE. Understanding the intention-to-treat principle in randomized controlled trials. West J Emerg Med. 2017;18(6):1075-1078. https://doi.org/10.5811/westjem.2017.8.35985
Amato KA, Reid ME, Ochs-Balcom HM, et al. Evaluation of a dedicated tobacco cessation support service for thoracic cancer center patients. J Public Health Manag Pract. 2018;24(5):E12-e19. https://doi.org/10.1097/phh.0000000000000674